Top compounds associated with response to WLS


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.023 0.6
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.021 0.6
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA Roscovitine GDSC1000 pan-cancer AAC 0.04 0.6
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.041 0.6
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.02 0.6
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
Download CSV